Select for export Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100702 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Nathalie M. Rieser, Ladina P Gubser, Franz X. Vollenweider, Meyer Lars, Katrin H. Preller OpenAlex Published psilocybin General Other More
Select for export Acute change in functional brain entropy following psilocybin administration in healthy volunteers No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100701 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M.K. Madsen, Gitte M. Knudsen OpenAlex Published psilocybin PharmacologyHealthy Volunteers Other More
Select for export Psilocybin may be effective for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.164911 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100102 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Nathalie M. Rieser, Ladina P Gubser, C. Rossgoderer Da Silva, Franz X. Vollenweider, Marcus Herdener, Katrin H. Preller OpenAlex Published psilocybin AddictionBiomarkers Other More
Select for export The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100213 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100511 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100410 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti OpenAlex Published psilocybin Pharmacology Other More
Select for export Should Adolescents be Included in Emerging Psychedelic Research? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7202/1089784ar Copy citation Copy BibTeX Canadian Journal of Bioethics 2021-12-31 Khaleel Rajwani OpenAlex Published psilocybin AdolescentsSafety Other More
Select for export Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.831092 PubMed 35370864 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Raison CL, Jain R, Penn AD, Cole SP, Jain S PubMed Published psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export The economics of psychedelic-assisted therapies: A research agenda. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1025726 PubMed 36545038 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Marseille E, Bertozzi S, Kahn JG PubMed Published psilocybin DepressionPTSDAddiction Other More
Select for export Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.32996/jmhs.2021.2.2.18 Copy citation Copy BibTeX Journal of Medical and Health Studies 2021-12-30 Victor Chiruta, Paulina K Zemla, Pixie Miller, Nicola Santarossa, John A Hannan OpenAlex Published psilocybin SafetyToxicity Other More
Select for export A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.727572 PubMed 34950063 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-12-06 Whitfield HJ. Europe PMC Published psilocybin DepressionPTSDMechanism of Action Review Article More
Select for export P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.394 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle OpenAlex Published psilocybin DepressionConsciousnessSafety Other More
Select for export Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2021.12.14 Copy citation Copy BibTeX Psychiatric News 2021-11-28 David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman OpenAlex Published psilocybin DepressionAnxietyConsciousness Clinical Trial More
Select for export Researchers hope psilocybin could improve quit rates for smokers Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/adaw.33270 Copy citation Copy BibTeX Alcoholism & Drug Abuse Weekly 2021-11-18 Gary Enos OpenAlex Published psilocybin Addiction Other More
Select for export Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-021-01706-y PubMed 34750350 Copy citation Copy BibTeX Translational Psychiatry 2021-11-07 Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.735523 PubMed 34744825 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-10-19 Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC Europe PMC Published psilocybin Eating DisordersEnd-of-Life DistressNeuroplasticity Clinical Trial More
Select for export Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-021-01603-4 PubMed 34601495 Copy citation Copy BibTeX Translational Psychiatry 2021-10-01 Vejmola Č, Tylš F, Piorecká V, Koudelka V, Kadeřábek L, Novák T Europe PMC Published psilocybinpsilocin Brain Imaging Other More
Select for export 6.3 CURRENT RESEARCH ON PSILOCYBIN TREATMENT ON END-OF-LIFE ANXIETY AND MDMA TREATMENT OF SOCIAL ANXIETY IN AUTISM SPECTRUM DISORDER No abstract availability was recorded for this entry. Details DOI 10.1016/j.jaac.2021.07.053 Copy citation Copy BibTeX Journal of the American Academy of Child & Adolescent Psychiatry 2021-09-30 Charles S. Grob OpenAlex Published psilocybin AnxietyEnd-of-Life DistressRandomized Controlled Trial Randomized Controlled Trial More
Select for export 6.2 OVERVIEW OF PSYCHEDELIC COMPOUNDS AND THEIR USE IN TREATMENT No abstract availability was recorded for this entry. Details DOI 10.1016/j.jaac.2021.07.052 Copy citation Copy BibTeX Journal of the American Academy of Child & Adolescent Psychiatry 2021-09-30 Matt T. Keener OpenAlex Published psilocybin Receptor Pharmacology Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.